Lord, Abbett & Co’s Pediatrix Medical MD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$5.2M Sell
242,972
-4,737
-2% -$98.6K 0.02% 449
2025
Q4
$5.3M Buy
+247,709
New +$5.08M 0.02% 456
2017
Q3
Sell
-237,629
Closed -$14.3M 903
2017
Q2
$14.3M Buy
+237,629
New +$14.1M 0.04% 530
2016
Q1
Sell
-685,878
Closed -$49.1M 918
2015
Q4
$49.1M Sell
685,878
-28,405
-4% -$2.1M 0.15% 205
2015
Q3
$54.9M Sell
714,283
-121,727
-15% -$9.82M 0.17% 188
2015
Q2
$62M Sell
836,010
-83,023
-9% -$5.98M 0.16% 183
2015
Q1
$66.6M Sell
919,033
-29,916
-3% -$2.08M 0.17% 171
2014
Q4
$62.7M Sell
948,949
-147,382
-13% -$9M 0.16% 167
2014
Q3
$60.1M Sell
1,096,331
-156,981
-13% -$8.91M 0.15% 171
2014
Q2
$72.9M Sell
1,253,312
-130,235
-9% -$7.66M 0.17% 168
2014
Q1
$85.8M Sell
1,383,547
-531,931
-28% -$30.9M 0.2% 148
2013
Q4
$102M Sell
1,915,478
-258,342
-12% -$13.9M 0.23% 118
2013
Q3
$109M Sell
2,173,820
-147,464
-6% -$7.2M 0.25% 110
2013
Q2
$106M Buy
+2,321,284
New +$104M 0.25% 102

Other funds holding MD

Lord, Abbett & Co's MD Position: Q1 2026 in Review

Lord, Abbett & Co reduced its Pediatrix Medical (MD) stake by 1.9% in Q1 2026, selling an estimated $98.6K and leaving 242,972 shares worth $5.2M. The position accounts for 0.02% of the portfolio, ranked #449.

Lord, Abbett & Co first reported a position in MD in Q2 2013 and has held it in 14 quarters since. The position peaked at $109M in Q3 2013. 296 funds tracked by Wall St. Rank hold MD as of Q1 2026.

  • Lord, Abbett & Co held 242,972 shares of Pediatrix Medical worth $5.2M as of Q1 2026.
  • Lord, Abbett & Co sold 4,737 Pediatrix Medical shares in Q1 2026, an estimated $98.6K.
  • Pediatrix Medical made up 0.02% of Lord, Abbett & Co's portfolio in Q1 2026, its #449 holding.
  • Lord, Abbett & Co first reported a position in Pediatrix Medical in Q2 2013 and has held it in 14 quarters since.
  • Lord, Abbett & Co's Pediatrix Medical position peaked at $109M in Q3 2013.
  • 296 funds tracked by Wall St. Rank held Pediatrix Medical as of Q1 2026.

Based on Lord, Abbett & Co's 13F filing for Q1 2026, filed 14 May 2026.